These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1988143)

  • 1. Development and characterization of a melphalan-resistant human multiple myeloma cell line.
    Bellamy WT; Dalton WS; Gleason MC; Grogan TM; Trent JM
    Cancer Res; 1991 Feb; 51(3):995-1002. PubMed ID: 1988143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
    Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
    Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro.
    Barranco SC; Townsend CM; Weintraub B; Beasley EG; MacLean KK; Shaeffer J; Liu NH; Schellenberg K
    Cancer Res; 1990 Jun; 50(12):3614-8. PubMed ID: 2340510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.
    Louie KG; Behrens BC; Kinsella TJ; Hamilton TC; Grotzinger KR; McKoy WM; Winker MA; Ozols RF
    Cancer Res; 1985 May; 45(5):2110-5. PubMed ID: 3986765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustards.
    Robson CN; Alexander J; Harris AL; Hickson ID
    Cancer Res; 1986 Dec; 46(12 Pt 1):6290-4. PubMed ID: 3779647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC; Colvin OM; Griffith OW; Bigner SH; Elion GB; Horton JK; Lilley E; Bigner DD; Friedman HS
    Cancer Res; 1989 Dec; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.
    Batist G; Torres-Garcia S; Demuys JM; Greene D; Lehnert S; Rochon M; Panasci L
    Mol Pharmacol; 1989 Aug; 36(2):224-30. PubMed ID: 2770701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation resistance in a melphalan-resistant subline of a rat mammary carcinoma.
    Lehnert S; Vestergaard J; Batist G; Aloui-Jamali MA
    Radiat Res; 1994 Aug; 139(2):232-9. PubMed ID: 8052700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Cancer Res; 1990 Aug; 50(15):4453-7. PubMed ID: 2369722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.
    Bellamy WT; Dorr RT; Dalton WS; Alberts DS
    Cancer Res; 1988 Nov; 48(22):6360-4. PubMed ID: 3180055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
    Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS
    Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
    Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
    Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.
    Hazlehurst LA; Enkemann SA; Beam CA; Argilagos RF; Painter J; Shain KH; Saporta S; Boulware D; Moscinski L; Alsina M; Dalton WS
    Cancer Res; 2003 Nov; 63(22):7900-6. PubMed ID: 14633719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
    Mulcahy RT; Untawale S; Gipp JJ
    Mol Pharmacol; 1994 Nov; 46(5):909-14. PubMed ID: 7969079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
    Moy BC; Petzold GL; Badiner GJ; Kelly RC; Aristoff PA; Adams EG; Li LH; Bhuyan BK
    Cancer Res; 1990 Apr; 50(8):2485-92. PubMed ID: 2317831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.